Immediate Impact
58 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of S Garancini being referenced
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy
2007
Immunoradiometric Assay of Chromogranin a in the Diagnosis of Small Cell Lung Cancer: Comparative Evaluation with Neuron-Specific Enolase
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| S Garancini | 100 | 287 | 116 | 222 | 172 | 20 | 557 | |
| Osama Al‐Saif | 66 | 142 | 110 | 194 | 110 | 29 | 466 | |
| Toshiyuki Fukuhara | 44 | 140 | 108 | 88 | 74 | 27 | 568 | |
| Thomas Rink | 115 | 252 | 135 | 213 | 173 | 22 | 523 | |
| Johan C. van Mourik | 86 | 172 | 32 | 199 | 79 | 21 | 627 | |
| Wick Mr | 22 | 136 | 59 | 120 | 154 | 29 | 474 | |
| S A Sohaib | 185 | 115 | 84 | 135 | 83 | 20 | 622 | |
| E. D. Staren | 31 | 175 | 85 | 301 | 107 | 18 | 555 | |
| Dimitrios Karantanis | 252 | 79 | 238 | 130 | 87 | 21 | 579 | |
| H Präuer | 12 | 266 | 44 | 334 | 193 | 25 | 557 | |
| Hasan Güçer | 9 | 201 | 126 | 206 | 109 | 35 | 506 |
All Works
Loading papers...